Login
$ESSI
$0.06 -$0.01 (12.38%) Close

Consolidated balance sheets

In millions of USD, except per-share amounts
Q2 FY2027
As of Jul 31, 2026
Q1 FY2027
As of Apr 30, 2026
Q4 FY2026
As of Jan 31, 2026
Q3 FY2026
As of Oct 31, 2025
Q2 FY2026
As of Jul 31, 2025
Q1 FY2026
As of Apr 30, 2025
Q4 FY2025
As of Jan 31, 2025
Q3 FY2025
As of Oct 31, 2024
Q2 FY2025
As of Jul 31, 2024
Q1 FY2025
As of Apr 30, 2024
Q4 FY2024
As of Jan 31, 2024
Q3 FY2024
As of Oct 31, 2023
Q4 FY2021
As of Jan 31, 2021
Q3 FY2021
As of Oct 31, 2020
Q2 FY2021
As of Jul 31, 2020
Q1 FY2021
As of Apr 30, 2020
Q4 FY2020
As of Jan 31, 2020
Q3 FY2020
As of Oct 31, 2019
Q1 FY2020
As of Apr 30, 2019
Q4 FY2019
As of Jan 31, 2019
Cash
Accounts receivable
Prepaid expenses
Total current assets
Intangible asset, net
TOTAL ASSETS
Current liabilities
Accounts payable and accrued expenses
Notes payable, short-term, related party
Related party payable
Customer deposits
Notes payable
Convertible note, net
Liabilities held on divestiture
Total current liabilities
Notes payable, net of current portion
Total liabilities
Commitments and contingencies
Stockholders' deficit
Preferred stock, $0.001 par, 50,000,000 shares authorized of which 1,000 shares are designated Series A Voting Preferred, none issued and outstanding
Common stock, $0.0001 par, 650,000,000 shares authorized, 24,992,656 shares issued and 24,952,656 shares outstanding
Treasury stock (1,000,000 shares issued at a cost of $0.0075 per share)
Treasury stock (40,000 shares issued at a cost of $0.1875 per share)
Additional paid in capital
Accumulated deficit
Total stockholders' deficit
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support